Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 20 di 336
Titolo Tipologia Data di pubblicazione Autore(i) File
D898_E901 RET Deletion Is Oncogenic, Responds to Selpercatinib, and Treatment Resistance Can Arise Via RET-Independent Mechanisms 1.1 Articolo in rivista 2023 Porcelli, Tommaso; Moccia, Marialuisa; DE STEFANO, MARIA ANGELA; Ambrosio, Raffaele; Capoluongo, Ettore Domenico; Santoro, Massimo; Hadoux, Julien; Schlumberger, Martin; Carlomagno, Francesca; Salvatore, Domenico
NCOA4 links iron bioavailability to DNA metabolism 1.1 Articolo in rivista 2022 Federico, Giorgia; Carrillo, Federica; Dapporto, Francesca; Chiariello, Mario; Santoro, Massimo; Bellelli, Roberto; Carlomagno, Francesca
Discovery of N-Trisubstituted Pyrimidine Derivatives as Type I RET and RET Gatekeeper Mutant Inhibitors with a Novel Kinase Binding Pose 1.1 Articolo in rivista 2022 Zhang, Lingtian; Moccia, Marialuisa; Briggs, David C; Bharate, Jaideep B; Lakkaniga, Naga Rajiv; Knowles, Phillip; Yan, Wei; Tran, Phuc; Kharbanda, Anupreet; Wang, Xiuqi; Leung, Yuet-Kin; Frett, Brendan; Santoro, Massimo; Mcdonald, Neil Q; Carlomagno, Francesca; Li, Hong-Yu
Targeted activity of the small molecule kinase inhibitor Pz-1 towards RET and TRK kinases 1.1 Articolo in rivista 2021 Moccia, M.; Yang, D.; Lakkaniga, N. R.; Frett, B.; Mcconnell, N.; Zhang, L.; Brescia, A.; Federico, G.; Zhang, L.; Salerno, P.; Santoro, M.; Li, H. -Y.; Carlomagno, F.
Discovery of pyrazolo-thieno[3,2-d]pyrimidinylamino-phenyl acetamides as type-II pan-tropomyosin receptor kinase (TRK) inhibitors: Design, synthesis, and biological evaluation 1.1 Articolo in rivista 2021 Yan, W.; Zhang, L.; Lv, F.; Moccia, M.; Carlomagno, F.; Landry, C.; Santoro, M.; Gosselet, F.; Frett, B.; Li, H. -Y.
The importance of the RET gene in thyroid cancer and therapeutic implications 1.1 Articolo in rivista 2021 Salvatore, D.; Santoro, M.; Schlumberger, M.
Ret gene fusions in malignancies of the thyroid and other tissues 1.8 Articolo in rassegna (review) 2020 Santoro, M.; Moccia, M.; Federico, G.; Carlomagno, F.
Bioisosteric discovery of npa101.3, a second-generation ret/vegfr2 inhibitor optimized for single-agent polypharmacology 1.1 Articolo in rivista 2020 Moccia, M.; Frett, B.; Zhang, L.; Lakkaniga, N. R.; Briggs, D. C.; Chauhan, R.; Brescia, A.; Federico, G.; Yan, W.; Santoro, M.; Mcdonald, N. Q.; Li, H. -Y.; Carlomagno, F.
Insights into Current Tropomyosin Receptor Kinase (TRK) Inhibitors: Development and Clinical Application 1.1 Articolo in rivista 2019 Yan, Wei; Lakkaniga, Naga Rajiv; Carlomagno, Francesca; Santoro, Massimo; Mcdonald, Neil Q.; Lv, Fengping; Gunaganti, Naresh; Frett, Brendan; Li, Hong-Yu
Association between DNA methylation profile and malignancy in follicular-patterned thyroid neoplasms 1.1 Articolo in rivista 2019 Affinito, Ornella; Salerno, Paolo; D'Alessio, Alfonso Manuel; Cuomo, Mariella; Florio, Ermanno; Carlomagno, Francesca; Proietti, Agnese; Giannini, Riccardo; Basolo, Fulvio; Chiariotti, Lorenzo; Cocozza, Sergio; Santoro, Massimo
Oncogene-induced senescence and its evasion in a mouse model of thyroid neoplasia 1.1 Articolo in rivista 2018 Bellelli, Roberto; Vitagliano, Donata; Federico, Giorgia; Marotta, Pina; Tamburrino, Anna; Salerno, Paolo; Paciello, Orlando; Papparella, Serenella; Knauf, Jeffrey A.; Fagin, James A.; Refetoff, Samuel; Troncone, Giancarlo; Santoro, Massimo
A dual mechanism of activation of the sonic hedgehog pathway in anaplastic thyroid cancer: Crosstalk with RAS-BRAF-MEK pathway and ligand secretion by tumor stroma 1.1 Articolo in rivista 2018 Parascandolo, Alessia; Laukkanen, Mikko O.; de Rosa, Nancy; Ugolini, Clara; Cantisani, MARIA CARMELA; Cirafici, Anna Maria; Basolo, Fulvio; Santoro, Massimo; Castellone, Maria Domenica
The molecular basis for RET tyrosine-kinase inhibitors in thyroid cancer 1.1 Articolo in rivista 2017 De Falco, Valentina; Carlomagno, Francesca; Li, Hong-yu; Santoro, Massimo
NCOA4 Links Iron Bioavailability to DNA Metabolism 1.1 Articolo in rivista 2017 Federico, G; Bellelli, R; Nai, A; Silvestri, L; Camaschella, C; Iolascon, A; Santoro, M; Carlomagno, F
Signal Transducer and Activator of Transcription 1 Plays a Pivotal Role in RET/PTC3 Oncogene-induced Expression of Indoleamine 2,3-Dioxygenase 1 1.1 Articolo in rivista 2017 Moretti, Sonia; Menicali, Elisa; Nucci, Nicole; Voce, Pasquale; Colella, Renato; Melillo, ROSA MARINA; Liotti, Federica; Morelli, Silvia; Fallarino, Francesca; Macchiarulo, Antonio; Santoro, Massimo; Avenia, Nicola; Puxeddu, Efisio
A loss-of-function genetic screening identifies novel mediators of thyroid cancer cell viability 1.1 Articolo in rivista 2016 Cantisani, MARIA CARMELA; Parascandolo, Alessia; Perälä, Merja; Allocca, Chiara; Fey, Vidal; Sahlberg, Niko; Merolla, Francesco; Basolo, Fulvio; Laukkanen, Mikko O; Kallioniemi, Olli Pekka; Santoro, Massimo; Castellone, Maria Domenica
NCOA4 Deficiency Impairs Systemic Iron Homeostasis 1.1 Articolo in rivista 2016 Bellelli, Roberto; Federico, Giorgia; Matte', Alessandro; Colecchia, David; Iolascon, Achille; Chiariello, Mario; Santoro, Massimo; De Franceschi, Lucia; Carlomagno, Francesca
Cross talk between the bombesin neuropeptide receptor and Sonic hedgehog pathways in small cell lung carcinoma 1.1 Articolo in rivista 2015 Castellone, M. D; Laukkanen, M. O; Teramoto, H; Bellelli, Roberto; Alì, G; Fontanini, G; Santoro, Massimo; Gutkind, J. S.
Fragment-Based Discovery of a Dual pan-RET/VEGFR2 Kinase Inhibitor Optimized for Single-Agent Polypharmacology 1.1 Articolo in rivista 2015 Frett, Brendan; Carlomagno, Francesca; Moccia, Marialuisa; Brescia, Annalisa; Federico, Giorgia; De Falco, Valentina; Admire, Brittany; Chen, Zhongzhu; Qi, Wenqing; Santoro, Massimo; Li, Hong yu
Identification of Novel Small Molecule Inhibitors of Oncogenic RET Kinase 1.1 Articolo in rivista 2015 Moccia, Marialuisa; Liu, Qingsong; Guida, Teresa; Federico, Giorgia; Brescia, Annalisa; Zhao, Zheng; Choi, Hwan Geun; Deng, Xianming; Tan, Li; Wang, Jinhua; Billaud, Marc; Gray, Nathanael S; Federico, Giorgia; Santoro, Massimo
Mostrati risultati da 1 a 20 di 336
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile